Next Article in Journal
Cannabinoids and Reproduction: A Lasting and Intriguing History
Next Article in Special Issue
Monoclonal Antibodies against Small Molecule Natural Products and Their Applications, Eastern Blotting and Knockout Extract
Previous Article in Journal
Allosteric Inhibitors of NMDA Receptor Functions
Previous Article in Special Issue
In Response to: ‘Impact of Glycosylation on Effector Functions of Therapeutic IgG’ (Pharmaceuticals 2010, 3, 146–157)
Article Menu

Export Article

Open AccessReview
Pharmaceuticals 2010, 3(10), 3258-3274;

The Role of Monoclonal Antibodies in the Management of Leukemia

Department of Leukemia, the University of Texas MD Anderson Cancer Center, Houston, TX 77005, USA
Department of Internal Medicine, Hematology Oncology section, Oklahoma University Health Sciences Center, 700 N.E. 13th Street, Oklahoma City, OK 74103, USA
Author to whom correspondence should be addressed.
Received: 20 September 2010 / Accepted: 18 October 2010 / Published: 18 October 2010
(This article belongs to the Special Issue Monoclonal Antibody)
Full-Text   |   PDF [133 KB, uploaded 18 October 2010]


This article will review the monoclonal antibodies more commonly used in leukemias. In the last three decades, scientists have made considerable progress understanding the structure and the functions of various surface antigens, such as CD20, CD33. The introduction of rituximab, an anti CD20 monoclonal antibody, had a great impact in the treatment of lymphoproliferative disorders. Gemtuzumab, an anti CD 33 conjugated monoclonal antibody has activity in acute mylegenous leukemia (AML). As this field is undergoing a rapid growth, the years will see an increasing use of monoclonal antibodies in hematological malignancies. View Full-Text
Keywords: monoclonal Abs; leukemia; CLL; AML; ALL monoclonal Abs; leukemia; CLL; AML; ALL
This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Share & Cite This Article

MDPI and ACS Style

Al-Ameri, A.; Cherry, M.; Al-Kali, A.; Ferrajoli, A. The Role of Monoclonal Antibodies in the Management of Leukemia. Pharmaceuticals 2010, 3, 3258-3274.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top